Evidence map›Paper›PMID 29973287›Full record

ArticleActa neuropathologica communications2018

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients.

Daniel A Mordes, Mercedes Prudencio, Lindsey D Goodman, Joseph R Klim, Rob Moccia, Francesco Limone, Olli Pietilainen, Kaitavjeet Chowdhary, Dennis W Dickson, Rosa Rademakers and 3 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Journal of developmental biology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. BV-2 Microglial Cells OverexpressingFrontiers in neurology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Daniel A MordesDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Mercedes PrudencioDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Lindsey D GoodmanDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Joseph R KlimDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Rob MocciaDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Francesco LimoneDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Olli PietilainenDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Kaitavjeet ChowdharyDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Rosa RademakersDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Nancy M BoniniDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Leonard PetrucelliDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
Kevin EgganDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA. eggan@mcb.harvard.edu.
Mayo Clinic in Florida · USHarvard Stem Cell Institute · USBroad Institute · USHarvard University · USUniversity of Pennsylvania · US

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Project 3: Neuropathology of the multi-proteinopathy of c9FTD/ALS.P01NS084974 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2014 to 2024
$17.6M
MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGYT32CA009216 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Michael Langenau · 1985 to 2026
$10.6M
Expanding insights into FTD disease mechanismsR35NS097273 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2017 to 2024
$10.6M
Molecular Genetic Insight into Neurodegenerative Disease from DrosophilaR35NS097275 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BONINI, NANCY M · 2017 to 2024
$6.0M
Stress Granules and the Biology of TDP-43R01ES020395 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2012 to 2016
$4.1M
TDP-43, RNA Metabolism, and ALS/FTD PathologyR01NS063964 · NINDS · UNIVERSITY OF COLORADO · PI LINK, CHRISTOPHER D. · 2009 to 2019
$3.5M
C9ORF72 in Motor System Biology and ALSR01NS089742 · NINDS · HARVARD UNIVERSITY · PI EGGAN, KEVIN C · 2014 to 2018
$2.3M
Misregulation of the TDP-43 RNA target, Sortilin, in neurodegenerationR01NS077402 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2011 to 2015
$1.7M
Silencing C9or72 with rAAV Mediated RNAiR01NS088689 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BROWN, ROBERT H., MUELLER, CHRISTIAN · 2014 to 2017
$1.6M
NCI NIH HHS T32 CA009216NIA NIH HHS P30 AG062421NIA NIH HHS P50 AG005134NIA NIH HHS P50 AG016574NIEHS NIH HHS R01 ES020395NINDS NIH HHS P01 NS084974NINDS NIH HHS R01 NS063964NINDS NIH HHS R01 NS077402NINDS NIH HHS R01 NS088689NINDS NIH HHS R01 NS089742NINDS NIH HHS R21 NS084528NINDS NIH HHS R35 NS097273NINDS NIH HHS R35 NS097275
6 · The paper itself

Abstract

A hexanucleotide (GGGGCC) repeat expansion in C9ORF72 is the most common genetic contributor to amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Reduced expression of the C9ORF72 gene product has been proposed as a potential contributor to disease pathogenesis. Additionally, repetitive RNAs and dipeptide repeat proteins (DPRs), such as poly-GR, can be produced by this hexanucleotide expansion that disrupt a number of cellular processes, potentially contributing to neural degeneration. To better discern which of these mechanisms leads to disease-associated changes in patient brains, we analyzed gene expression data generated from the cortex and cerebellum. We found that transcripts encoding heat shock proteins (HSPs) regulated by the HSF1 transcription factor were significantly induced in C9ORF72-ALS/FTLD patients relative to both sporadic ALS/FTLD cases and controls. Treatment of human neurons with chemically synthesized DPRs was sufficient to activate a similar transcriptional response. Expression of GGGGCC repeats and also poly-GR in the brains of Drosophila lead to the upregulation of HSF1 and the same highly-conserved HSPs. Additionally, HSF1 was a modifier of poly-GR toxicity in Drosophila. Our results suggest that the expression of DPRs are associated with upregulation of HSF1 and activation of a heat shock response in C9ORF72-ALS/FTLD.

Indexed as

AnimalsBrainC9orf72 ProteinCohort StudiesDipeptidesDisease Models, AnimalDNA Repeat ExpansionDrosophilaEyeFemaleFrontotemporal Lobar DegenerationGene Expression RegulationGlial Fibrillary Acidic ProteinHeat-Shock ResponseHeat Shock Transcription FactorsHumansC9orf72 ProteinDipeptidesGlial Fibrillary Acidic ProteinHeat Shock Transcription FactorsAmyotrophic lateral sclerosisC9ORF72 repeat expansionDipeptide repeat proteinsDrosophilaFrontotemporal dementiaFrontotemporal lobar degenerationHeat shock responseHSF1

Identifiers

PMID29973287
PMCPMC6031111
OpenAlexW2809958519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.